Merck KGaA (OTCMKTS:MKGAF – Get Free Report)’s stock price was down 7.7% on Thursday . The company traded as low as $124.2190 and last traded at $124.2250. Approximately 66 shares changed hands during trading, a decline of 93% from the average daily volume of 901 shares. The stock had previously closed at $134.5750.
Merck KGaA Price Performance
The stock’s 50-day simple moving average is $133.16 and its two-hundred day simple moving average is $132.02. The company has a market capitalization of $17.21 billion, a price-to-earnings ratio of 20.32 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27.
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Featured Stories
- Five stocks we like better than Merck KGaA
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Lowe’s Stock Price Signals a Buying Opportunity After Q3 Release
- Best Energy Stocks – Energy Stocks to Buy Now
- NVIDIA Just Proved the AI Boom Is Bigger Than Anyone Thought
- What is the Nasdaq? Complete Overview with History
- Why Target Stock May Keep Falling Despite a 5% Dividend Yield
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
